22237003: Prostaglandin PGE>2< (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

37328016 Prostaglandin PGE>2< en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

37329012 Dinoprostone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

751622019 Prostaglandin PGE>2< (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Prostaglandin PGE>2<	Is a	Prostaglandin	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Prostaglandin PGE2 measurement (procedure)	Has measured component (attribute)	False	Prostaglandin PGE>2<	Inferred relationship	Some
Prostaglandin PGE2 measurement (procedure)	Component	False	Prostaglandin PGE>2<	Inferred relationship	Some
Dinoprostone 10mg suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prostaglandin PGE>2<	Inferred relationship	Some
dinoprostone 1 mg/mL, ampoule de 0,75 mL de concentré pour perfusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prostaglandin PGE>2<	Inferred relationship	Some
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prostaglandin PGE>2<	Inferred relationship	Some
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré avec diluant pour injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prostaglandin PGE>2<	Inferred relationship	Some
Dinoprostone 400 microgram/mL vaginal gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prostaglandin PGE>2<	Inferred relationship	Some
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prostaglandin PGE>2<	Inferred relationship	Some
Dinoprostone 3 mg vaginal tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prostaglandin PGE>2<	Inferred relationship	Some
Product containing dinoprostone in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prostaglandin PGE>2<	Inferred relationship	Some
Dinoprostone-containing product in vaginal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prostaglandin PGE>2<	Inferred relationship	Some
Dinoprostone 10mg insert	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prostaglandin PGE>2<	Inferred relationship	Some

Reference Sets

Concept inactivation indicator reference set

SAME AS association reference set (foundation metadata concept)